Latest Breaking News On - Director kevin bitterman - Page 3 : comparemela.com

Morgan Stanley Trims Disc Medicine (NASDAQ:IRON) Target Price to $40 00

Disc Medicine (NASDAQ:IRON – Get Free Report) had its price objective cut by Morgan Stanley from $75.00 to $40.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price suggests a potential upside of 26.78% from the stock’s previous close. A […]

Kevin bittermanStifel nicolausRaymond jamesRenaissance technologiesCitigroup incVenture fund xlp atlasGeode capital managementSecurities exchange commissionDisc medicine incMorgan stanleyMillennium managementDisc medicineGet free reportMedicine trading downDirector kevin bittermanExchange commission

Morgan Stanley Trims Disc Medicine (NASDAQ:IRON) Target Price to $40 00

Disc Medicine (NASDAQ:IRON – Get Free Report) had its price objective cut by Morgan Stanley from $75.00 to $40.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price suggests a potential upside of 26.78% from the stock’s previous close. A […]

Raymond jamesStifel nicolausKevin bittermanGeode capital managementVenture fund xlp atlasCitigroup incRenaissance technologiesMillennium managementMorgan stanleyDisc medicine incSecurities exchange commissionDisc medicineGet free reportMedicine trading downDirector kevin bittermanExchange commission

Disc Medicine (NASDAQ:IRON) Shares Gap Down to $62 26

Disc Medicine (NASDAQ:IRON) Shares Gap Down to $62 26
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Raymond jamesKevin bittermanDisc medicine incCantor fitzgeraldCitadel advisorsPolar capital holdings plcBlackrock incPerceptive advisorsVenture fund xlp atlasSecurities exchange commissionMorgan stanleyDisc medicineGet free reportDirector kevin bittermanVenture fundExchange commission

Disc Medicine (NASDAQ:IRON) Earns Buy Rating from HC Wainwright

Disc Medicine (NASDAQ:IRON) Earns Buy Rating from HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Kevin bittermanDisc medicine company profileCitadel advisorsPerceptive advisorsVanguard group incVenture fund xlp atlasDisc medicine incFrazier life sciences managementCantor fitzgeraldMorgan stanleyDisc medicineFree reportMedicine trading downGet free reportDirector kevin bittermanVenture fund

Disc Medicine (NASDAQ:IRON) Rating Reiterated by Wedbush

Disc Medicine (NASDAQ:IRON) Rating Reiterated by Wedbush
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Kevin bittermanSecurities exchange commissionFrazier life sciences managementPerceptive advisorsDisc medicine incMorgan stanleyVenture fund xlp atlasVanguard group incCitadel advisorsCantor fitzgeraldDisc medicineFree reportMedicine trading downDirector kevin bittermanVenture fundExchange commission